Search the reporting

Results for "FDA"

Search by issue, actor, mechanism, or public cost. The route should feel like a real reporting entry point, not a utility page stranded off to the side.

contracts appointments records rates

Live lenses8

Reporting entries767

Active query"FDA"

3 results found

Results stay in the same editorial order as the current reporting set, so search behaves like a discovery route rather than a ranked feed.

ReportingPublic Impact

3 min readJuly 24, 2026

US cyclosporiasis outbreak expands to nine states as CDC investigates over 7,400 cases

Investigations into the largest cyclosporiasis outbreak on record expanded to nine states this week, as more than 11,500 people are suspected to have been sickened this summer, according to reports and the Centers for Disease Control and Prevention (CDC).

Why it matters: Investigations into the largest cyclosporiasis outbreak on record expanded to nine states this week, as more than 11,500 people are suspected to have been sickened this summer, according to reports and the Centers for Disease Control and Prevention (CDC).

Read lead result Open lens

ReportingPublic Impact

3 min readJuly 18, 2026

Taylor Farms recalls lettuce shipped to 27 states over cyclospora risk

“We are actively removing the implicated products,” the statement said, adding that the company has stopped sourcing lettuce from an implicated lot in central Mexico. U.S. health officials earlier this week identified lettuce from a supplier in Mexico as a source of cyclospora contamination in food served at Taco Bell restaurants in five Midwestern states.

Why it matters: “We are actively removing the implicated products,” the statement said, adding that the company has stopped sourcing lettuce from an implicated lot in central Mexico. U.S. health officials earlier this week identified lettuce from a supplier in Mexico as a source of cyclospora contamination in food served at Taco Bell restaurants in five Midwestern states.

Read story

ArchiveInstitutional Decay

1 min readApril 22, 2026

FDA weighs easing limits on peptide use

The FDA is considering easing limits on peptide use. That could open the door to wider access, but it could also weaken a safeguard that was put there for a reason. The move: Th...

Why it matters: The FDA is considering easing limits on peptide use. That could open the door to wider access, but it could also weaken a safeguard that was put there for a reason. The move: Th...

Read story